prohance 279,3 mg/ml injektionslösung
bracco imaging deutschland - gadoteridol - injektionslösung - 279,3 mg/ml - gadoteridol 279.3 mg/ml - gadoteridol
prohance solution for injection 279.3 mg/m mg/ml
bracco international b.v. - gadoteridol - solution for injection - 279.3 mg/m mg/ml
prohance 0.5mmol/ml solution for injection 10ml pre-filled syringes
bracco uk ltd - gadoteridol - solution for injection - .5mmol/1ml
prohance 0.5mmol/ml solution for injection 17ml pre-filled syringes
bracco uk ltd - gadoteridol - solution for injection - .5mmol/1ml
prohance 0.5mmol/ml solution for injection 10ml vials
bracco uk ltd - gadoteridol - solution for injection - .5mmol/1ml
prohance 0.5mmol/ml solution for injection 15ml vials
bracco uk ltd - gadoteridol - solution for injection - .5mmol/1ml
prohance 0.5mmol/ml solution for injection 20ml vials
bracco uk ltd - gadoteridol - solution for injection - .5mmol/1ml
prohance 279,3 mg/ml solucion inyectable
bracco imaging spa, italy - gadoteridolum - Šķīdums injekcijām
prohance solución inyectable
quimica mediq - solución inyectable - gadoteridol 0,5 mmol/ml (279,3 mg/ml) inyectable
prohance 4748,10 mg/17 ml, solution injectable en seringue pré-remplie
bracco imaging france - gadotéridol - solution - 4748,10 mg - composition pour une seringue préremplie de 17 ml > gadotéridol : 4748,10 mg - produit de contraste pour imagerie par résonance magnétique